These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22820452)

  • 1. Release pathways of interferon α2a molecules from lipid twin screw extrudates revealed by single molecule fluorescence microscopy.
    Sax G; Feil F; Schulze S; Jung C; Bräuchle C; Winter G
    J Control Release; 2012 Sep; 162(2):295-302. PubMed ID: 22820452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
    Schulze S; Winter G
    J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants.
    Sax G; Winter G
    J Control Release; 2012 Oct; 163(2):187-94. PubMed ID: 22964391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Herrmann S; Mohl S; Siepmann F; Siepmann J; Winter G
    Pharm Res; 2007 Aug; 24(8):1527-37. PubMed ID: 17380261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Herrmann S; Winter G; Mohl S; Siepmann F; Siepmann J
    J Control Release; 2007 Apr; 118(2):161-8. PubMed ID: 17275943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution from solid lipid extrudates containing release modifiers.
    Güres S; Kleinebudde P
    Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo biodegradation of extruded lipid implants in rabbits.
    Sax G; Kessler B; Wolf E; Winter G
    J Control Release; 2012 Oct; 163(2):195-202. PubMed ID: 22964393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of implant composition of twin-screw extruded lipid implants on the release behavior.
    Even MP; Bobbala S; Kooi KL; Hook S; Winter G; Engert J
    Int J Pharm; 2015 Sep; 493(1-2):102-10. PubMed ID: 26188320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implants.
    Schönbrodt T; Mohl S; Winter G; Reich G
    J Control Release; 2006 Aug; 114(2):261-7. PubMed ID: 16872710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule fluorescence microscopy to determine phospholipid lateral diffusion.
    Murcia MJ; Garg S; Naumann CA
    Methods Mol Biol; 2007; 400():277-94. PubMed ID: 17951741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and biophysical characterization of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers.
    Dhalluin C; Ross A; Leuthold LA; Foser S; Gsell B; Müller F; Senn H
    Bioconjug Chem; 2005; 16(3):504-17. PubMed ID: 15898716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of change of matrix crystallinity and polymorphism on ovalbumin release from lipid-based implants.
    Duque L; Körber M; Bodmeier R
    Eur J Pharm Sci; 2018 May; 117():128-137. PubMed ID: 29452211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous release of rh-interferon alpha-2a from triglyceride matrices.
    Mohl S; Winter G
    J Control Release; 2004 May; 97(1):67-78. PubMed ID: 15147805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of protein release from triglyceride microspheres.
    Zaky A; Elbakry A; Ehmer A; Breunig M; Goepferich A
    J Control Release; 2010 Oct; 147(2):202-10. PubMed ID: 20659511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.
    Dhalluin C; Ross A; Huber W; Gerber P; Brugger D; Gsell B; Senn H
    Bioconjug Chem; 2005; 16(3):518-27. PubMed ID: 15898717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.